EMBL Australia

Opportunities are available for students interested in the EMBL Australia PhD Course, travel grants for PhD students and postdoctoral fellows and financial support for the 19th EMBL PhD Symposium in Heidelberg.

Dr Yannick Schwab, team leader and head of electron microscopy core facility at EMBL, will travel from EMBL Heidelberg to join us and 60 first and second-year PhD students at the EMBL Australia PhD Course in July at Monash University.

Alex Ma, Katharina Gaus and their colleagues have developed a fluorescence membrane charge sensor (MCS) that reports changes in electrostatic interactions at the inner leaflet of the plasma membrane in live cells.

Professor Alan Cooper, the 2016 South Australian Scientist of the Year and prominent ancient DNA researcher, will give a plenary address to the students at our PhD Course in July.

His passion for regenerative medicine has seen him work all over the world and now Dr Harald Janovjak is bringing his expertise to EMBL Australia as a group leader based at the Australian Regenerative Medicine Institute at Monash University either later this year or in early 2018.

In collaboration with an assembly of highly recognised international scientists, EMBL Australia group leader Chen Davidovich and Nobel Laureate Thomas Cech (Howard Hughes Medical Institute and University of Colorado at Boulder) have discovered how a gene-suppressing enzyme recognises genes product.

Morgan Oatley is one of Australia’s first students to enter the esteemed EMBL International PhD Programme. Read our interview with Morgan about the programming and studying abroad.

Seven years since it started in 2009, the Victorian Life Sciences Computation Initiative (VLSCI) has re-launched as Melbourne Bioinformatics.

The UNSW in collaboration with EMBL Australia are hosting international scientists during a mini-sabbatical to work more closely with the team at the EMBL Australia Node of Single Molecule Science at UNSW. Join us to exchange ideas, develop collaborations, and take advantage of our facilities, which includes a suite of powerful imaging tools.

Throughout 2016 Associate Professor Max Cryle and his collaborators, from the Max Planck Institute for Medical Research, have used published molecular structures of antibiotic resistant golden staph (Staphylococcus aureus), to see how we might overcome the resistance with new super-antibiotics.